Efficacy of Shenqi Pollen Capsules for High-Altitude Deacclimatization Syndrome via Suppression of the Reoxygenation Injury and Inflammatory Response
Table 1
Baseline characteristics of subjects at randomization according to the study group.
SPC group ()
Placebo group ()
value
Demographic characteristics
Chongqing (180 m) (%)
44 (30.13%)
42 (29.58%)
0.92
Kunming (1800 m) (%)
34 (23.29%)
33 (23.24%)
0.99
Zhengzhou (110 m) (%)
38 (26.03%)
37 (26.06%)
0.95
Wuwei (1500 m) (%)
30 (20.55%)
30 (21.12%)
0.90
Age, years (SD, range)
25.09 (5.08, 18-35)
24.60 (4.66, 18-34)
0.40
Race, Han (%)
146 (100%)
142 (100%)
1.00
Sex, male (%)
146 (100%)
142 (100%)
1.00
Work intensity
Mild
42 (28.77%)
44 (30.98%)
0.42
Moderate
86 (58.90%)
88 (61.97%)
0.63
Severe
14 (9.58)
14 (9.85%)
0.94
Smoking
114 (78.08%)
106 (74.64%)
0.49
Alcohol consumption
113 (77.39%)
109 (76.76%)
0.90
AMS occurrence
19 (13.01%)
17 (11.97%)
0.79
The data are presented as (%) or the mean ((SD; range) or (SE, 95% CI)). AMS occurrence: subjects suffered from acute mountain sickness (AMS) at high altitude. Statistical differences between groups were tested for using a test for quantitative data and a chi-square test for categorical data.
